Low-Dose Naltrexone Side Effects: What the Trials Measured and How Long They Last

01The Short Answer

What Are the Side Effects of Low-Dose Naltrexone?

The side effects of low-dose naltrexone that patients report most often are vivid or unusual dreams, disturbed sleep, headache, nausea, fatigue and reduced appetite. Low-dose naltrexone, or LDN, means naltrexone prescribed at roughly 1 to 5 mg a day instead of the 50 mg dose the FDA approved for alcohol and opioid use disorder. At that fraction of the dose, the adverse-event profile recorded in trials is mild and front-loaded.

• Vivid, unusual or more memorable dreams
• Trouble falling asleep or staying asleep
• Headache
• Nausea or brief digestive upset
• Fatigue or a change in daytime energy
• Reduced appetite

Two things matter more than that list. The first is that only one of these effects has separated from placebo in pooled randomized data. The second is that LDN must never be combined with opioid medication, which is a safety rule rather than a side effect. Protocol Health prescribes low-dose naltrexone, so read this page as information from a clinic that has a commercial interest in the treatment, and check it against your own physician. Those six symptoms are the bulk of what the LDN literature records, and most patients who get them get them early.

02How Common They Are

How Common Are Low-Dose Naltrexone Side Effects in Clinical Trials?

Low-dose naltrexone side effects were common enough to count in clinical trials, but only vivid dreams occurred significantly more often on LDN than on placebo. A 2025 systematic review and meta-analysis of five randomized trials in fibromyalgia found vivid dreams at a relative risk of 2.41, with a 95% confidence interval of 1.77 to 3.28. That interval sits entirely above 1.0, which is the statistical way of saying the effect is real rather than noise.

Headache is the interesting one, because every competing page lists it and the pooled data do not support it. In the same meta-analysis, headache carried a relative risk of 1.68 with a 95% confidence interval of 0.84 to 3.36. That interval crosses 1.0, so the trials could not separate headache on LDN from headache on placebo. The authors reported no serious adverse effects in the treatment group.

The picture from Crohn's disease is the same shape. A 2018 Cochrane review of two randomized trials pooled 46 participants and found no statistically significant differences in withdrawals due to adverse events, or in sleep disturbance, unusual dreams, headache, decreased appetite, nausea or fatigue. No serious adverse events were reported in either study.

So the honest frequency answer is that LDN side effects are common in the sense that patients notice them and uncommon in the sense that almost none of them outrun placebo. Vivid dreams are the exception, and they are the thing to expect if you expect anything.

03Vivid Dreams and Sleep

Vivid Dreams and Sleep Disturbance on LDN

Vivid dreams and sleep disturbance are the LDN side effect with the strongest signal in the randomized data, and they are also the most reported one in clinical practice. Naltrexone blocks opioid receptors transiently, and the published trials gave it at night, so the hours of blockade overlap the part of the night richest in REM sleep. Patients describe dreams that are longer, stranger and easier to remember rather than frightening.

Timing is the usual lever, and it belongs to the prescriber rather than to the patient. Trials of LDN in fibromyalgia and Crohn's disease used 4.5 mg at bedtime, and clinicians who see persistent dream disturbance commonly move the dose to the morning or step it down before stepping it back up. None of that is a self-administration instruction. Your prescribing physician sets the dose and the timing against your history, your medication list and your labs.

These dreams did not drive people out of the studies, because withdrawals due to adverse events were no higher on LDN than on placebo. Strange dreams on LDN are best raised at follow-up rather than treated as a reason to stop on your own.

04How Long They Last

How Long Do Low-Dose Naltrexone Side Effects Last?

Low-dose naltrexone side effects usually do not last long, with most clinical reports placing them in the first days to the first few weeks of treatment. That answer deserves an asterisk, and most pages do not give it one. The randomized trials counted adverse events at the end of the study rather than tracking when each one resolved, so there is no published resolution curve for LDN side effects. The short-lived pattern is clinical observation, not trial data.

What the trials do establish is that the effects were not severe enough to end participation. In the pooled Crohn's trials there was no significant difference in withdrawals due to adverse events between LDN and placebo, and in the fibromyalgia meta-analysis no serious adverse effects were reported. People finished the studies.

Titration is the practical reason early effects tend to shrink. Clinicians commonly start LDN below the target dose and raise it in steps. A symptom that appears the day a dose goes up and fades over the following week behaves like an adjustment effect; one that arrives weeks into a stable dose does not. Effects that persist past the first month are a reason to reassess the dose with your physician.

05Long-Term Safety

Long-Term Side Effects of Low-Dose Naltrexone

The long-term side effects of low-dose naltrexone are largely unmeasured, because the controlled trials ran for weeks to months rather than years. The Crohn's trials in the Cochrane review ran 8 and 12 weeks. The fibromyalgia trials were similarly short, typically around 12 weeks. Nobody has published a randomized LDN trial long enough to describe what years of use do, so any page that tells you LDN is proven safe long term is going beyond its evidence.

What exists instead is the long safety record of naltrexone at its approved 50 mg dose, which is roughly ten times what LDN uses. That record is reassuring about the molecule and only indirectly about the protocol. It is also the reason the serious symptoms listed on the MedlinePlus naltrexone monograph are worth knowing at any dose: excessive tiredness, unusual bleeding or bruising, pain in the upper right part of the stomach, light-colored bowel movements, dark urine, yellowing of the skin or eyes, confusion, hallucinations, blurred vision, severe vomiting or diarrhea, and thoughts of suicide. Those warrant a call to your doctor or emergency care, not a wait-and-see.

Two regulatory facts belong in any honest long-term discussion. LDN is an off-label use: naltrexone is FDA-approved at 50 mg for alcohol and opioid use disorder, and it is not FDA-approved for pain, inflammation, autoimmune conditions or weight. The low doses are almost always compounded, and compounded preparations are not FDA-approved. Off-label prescribing is legal and ordinary, but it is not the same as an approved indication. Long-term LDN use is a decision to revisit with your physician on a schedule, not a question the literature has settled.

06What to Avoid

What to Avoid When Taking Low-Dose Naltrexone

What to avoid when taking low-dose naltrexone starts with opioids, which must not be combined with naltrexone at any dose. The rest of the list is shorter than the internet suggests, and alcohol is more nuanced than most pages make it.

Opioid Medications and Opioid Street Drugs

Opioid medications and opioid street drugs are the one absolute conflict with naltrexone. Naltrexone is an opioid antagonist, so it blocks them, and taking it while opioids are still in your system can precipitate withdrawal. MedlinePlus states that naltrexone may cause or worsen withdrawal symptoms, and that you should not take it if you have recently stopped using opioid medications or opioid street drugs and are now in withdrawal. The window it names is 7 to 10 days since any opioid, including methadone, buprenorphine and opioid-containing medicines for cough or diarrhea. Disclose every one of those to your prescriber before starting LDN.

Planned Surgery and Acute Pain

Planned surgery and acute pain need to be raised with your prescriber in advance, because naltrexone blunts the opioid painkillers used for both. An elective procedure, a dental extraction and an injury that might need stronger analgesia all belong on the list you discuss before starting. Carrying a note of your LDN prescription is sensible for the same reason pain and injury recovery planning is: the people treating you in an emergency need to know.

Alcohol

Alcohol is not listed among the reasons to avoid naltrexone on the MedlinePlus naltrexone monograph, which describes the drug at its approved dose as a treatment that reduces the craving for alcohol. That does not make drinking on LDN risk-free. Naltrexone carries liver warnings, and heavy alcohol use strains the same organ, so how much you drink is a question to answer honestly with your prescriber before starting.

Beyond opioids, surgery and an honest liver conversation, the list of things to avoid on LDN is short. The habit worth avoiding is starting it without telling your prescriber what else you take.

07Who Should Not Take It

Who Should Not Take Low-Dose Naltrexone

You should not take low-dose naltrexone if you are currently using opioids or are in opioid withdrawal, and LDN needs careful weighing in several other situations. Candidacy is a clinical decision made on your full history, not a checklist you can clear yourself.

• Anyone taking opioid pain medication, methadone or buprenorphine, or who has used opioids in the last 7 to 10 days
• Anyone currently experiencing opioid withdrawal
• Anyone with liver disease, which the MedlinePlus monograph lists among the conditions to disclose before starting naltrexone
• Anyone with a history of depression or suicidal thoughts, which the same monograph lists
• Anyone with kidney disease
• Anyone pregnant, planning pregnancy or breastfeeding
• Anyone with surgery or a procedure scheduled in the near term

None of those is automatically disqualifying apart from current opioid use, and that is the point of a consultation. People who should not take low-dose naltrexone are identified by that review, not by a page like this one.

08Stopping LDN

Side Effects of Stopping Low-Dose Naltrexone

The side effects of stopping low-dose naltrexone are not withdrawal, because naltrexone is an opioid antagonist rather than an opioid and the body does not become physically dependent on it. People who stop LDN do not get a discontinuation syndrome the way they might coming off some antidepressants or benzodiazepines.

What people do notice is the return of whatever they were treating. If LDN was helping pain or sleep, the benefit recedes over days to weeks once the drug is gone. That is a loss of effect, not a withdrawal reaction, and the distinction matters because the two call for different responses. One is a reason to revisit the prescription; the other would be a reason to taper.

Stopping is still a decision to make with your prescriber, because naltrexone blocks opioid painkillers while you take it and stops blocking them when you do not. If you are considering stopping low-dose naltrexone, raise it at a visit rather than simply discontinuing.

09How Much Evidence There Is

How Much Evidence Sits Behind the LDN Side Effect Numbers?

Not much evidence sits behind the LDN side effect numbers that circulate online, and saying so is the most useful thing this page can do. The 2018 Cochrane review that is cited everywhere for LDN tolerability pooled two randomized trials totalling 46 participants. Cochrane rated the overall quality of that evidence as low, specifically for serious imprecision from sparse data, and concluded that there is insufficient evidence to allow any firm conclusions about the efficacy and safety of LDN in active Crohn's disease.

The fibromyalgia meta-analysis is larger but not large. It pooled five randomized trials, enough to produce a confidence interval and not enough to detect anything rare. A side effect occurring in one patient in a thousand would be invisible in a dataset that size, which is why no one can yet make a strong statement about uncommon or long-delayed LDN effects.

There is a real asymmetry worth naming. A 2018 Pharmacotherapy review of LDN in multiple sclerosis, fibromyalgia and Crohn's disease concluded that current evidence supports its safety and tolerability while fewer studies support its efficacy, and that further randomized trials are needed. In other words the tolerability case for LDN is better supported than the benefit case, which is an unusual position for a medication and one a prescriber should put to you plainly. Our companion guide to low-dose naltrexone benefits sets out that efficacy evidence, including the large 2024 trial that found no benefit over placebo. The honest summary of the LDN side effect literature is that it is reassuring, thin, and short.

10The Protocol Health Approach

How Protocol Health Handles Low-Dose Naltrexone Side Effects

Protocol Health handles low-dose naltrexone side effects by setting the starting dose against your history and labs, then adjusting it at follow-up rather than leaving you to ride them out. Protocol Health is a family-owned, physician-led clinic that prescribes LDN, which is the commercial interest you should weigh when reading anything we publish about it.

The first conversation is about your medication list, because current opioid use rules LDN out and a scheduled procedure changes the plan. From there a physician decides whether LDN fits, sets the dose and the timing, and books the follow-up where the dream, sleep and headache questions on this page get answered against your experience rather than a trial average.

Patients are seen in person at the Scarsdale clinic at 700 White Plains Rd #30, and by telehealth across New York, New Jersey, Connecticut, Florida and California. Pricing depends on your plan, and a consultation is the first step. If you are weighing whether the side effects are worth it, have that conversation with a physician who can see your labs and history rather than a symptom list. The tolerability of low-dose naltrexone is individual.

FAQ

Frequently Asked Questions

Explore

Related at Protocol Health

• Low-Dose Naltrexone (LDN) →
• Low-Dose Naltrexone Benefits →
• Pain & Injury Recovery →
• Longevity & Preventive Health →